Philadelphia Magazine: This Philly Scientist’s Technology Helped Make The Pfizer COVID-19 Vaccine Possible

This week, American pharmaceutical corporation Pfizer and German biotechnology company BioNTech released preliminary results from their Phase III clinical trial that showed the companies’ vaccine candidate could be highly effective in preventing COVID-19 infections. According to interim data not yet published in a peer-reviewed journal, the vaccine was 90 percent effective at protecting trial participants who received two injections of the vaccine when compared to participants who received a placebo shot.

View full article in Philadelphia Magazine.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Philadelphia Community partner.